Aequus Pharmaceuticals (AEQ) Financial Statements
Aequus Pharmaceuticals Financial Overview
Aequus Pharmaceuticals's market cap is currently $423.50K. The company's EPS TTM is $-0.01; its P/E ratio is 3.13; Aequus Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 25 | Mar 24 | Mar 23 | Dec 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 584.24K | $ 254.90K | $ 1.38M | $ 2.71M | $ 2.59M |
| Gross Profit | $ 199.97K | $ 143.66K | $ 1.15M | $ 2.69M | $ 2.59M |
| Operating Income | $ -2.13M | $ -2.82M | $ -2.50M | $ -1.35M | $ -521.57K |
| EBITDA | $ -1.79M | $ -2.68M | $ -2.87M | $ -1.23M | $ -314.80K |
| Net Income | $ -2.18M | $ -2.96M | $ -3.21M | $ -1.81M | $ -1.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 50.24K | $ 170.20K | $ 294.67K | $ 2.39M | $ 1.72M |
| Total Assets | $ 800.28K | $ 1.09M | $ 1.69M | $ 4.35M | $ 3.13M |
| Total Debt | $ 6.61M | $ 5.06M | $ 782.92K | $ 2.18M | $ 2.32M |
| Net Debt | $ 6.56M | $ 4.89M | $ 533.10K | $ -211.31K | $ 604.74K |
| Total Liabilities | $ 7.26M | $ 5.38M | $ 3.07M | $ 2.56M | $ 2.56M |
| Stockholders' Equity | $ -6.45M | $ -4.29M | $ -1.38M | $ 1.79M | $ 573.95K |
| Cash Flow | |||||
| Free Cash Flow | $ -1.66M | $ -2.29M | $ -1.95M | $ -1.18M | $ -817.23K |
| Operating Cash Flow | $ -1.66M | $ -2.29M | $ -1.95M | $ -1.17M | $ -804.91K |
| Investing Cash Flow | $ 44.85K | $ 0.00 | $ 0.00 | $ -507.96K | $ -12.32K |
| Financing Cash Flow | $ 1.49M | $ 2.21M | $ -189.19K | $ 2.40M | $ 2.05M |
Currency in CAD